![IJERPH | Free Full-Text | Efficacy of Denosumab Therapy Following Treatment with Bisphosphonates in Women with Osteoporosis: A Cohort Study IJERPH | Free Full-Text | Efficacy of Denosumab Therapy Following Treatment with Bisphosphonates in Women with Osteoporosis: A Cohort Study](https://www.mdpi.com/ijerph/ijerph-18-01728/article_deploy/html/images/ijerph-18-01728-g001.png)
IJERPH | Free Full-Text | Efficacy of Denosumab Therapy Following Treatment with Bisphosphonates in Women with Osteoporosis: A Cohort Study
Denosumab 60mg injection (Prolia®) for Osteoporosis in Post- menopausal Women and Men (over 50 years) in Primary Care Prescribi
![Combination denosumab and high dose teriparatide for postmenopausal osteoporosis (DATA-HD): a randomised, controlled phase 4 trial - The Lancet Diabetes & Endocrinology Combination denosumab and high dose teriparatide for postmenopausal osteoporosis (DATA-HD): a randomised, controlled phase 4 trial - The Lancet Diabetes & Endocrinology](https://www.thelancet.com/cms/attachment/de4069cd-afe5-441f-a714-97595f412c53/gr1.gif)
Combination denosumab and high dose teriparatide for postmenopausal osteoporosis (DATA-HD): a randomised, controlled phase 4 trial - The Lancet Diabetes & Endocrinology
![Combination denosumab and high dose teriparatide for postmenopausal osteoporosis (DATA-HD): a randomised, controlled phase 4 trial - The Lancet Diabetes & Endocrinology Combination denosumab and high dose teriparatide for postmenopausal osteoporosis (DATA-HD): a randomised, controlled phase 4 trial - The Lancet Diabetes & Endocrinology](https://www.thelancet.com/cms/attachment/943b600b-7b97-49a7-b86a-3688244b094f/gr2_lrg.jpg)